EU Commission clears acquisition of Unilabs by APMH Invest

The European Commission has approved on January 21, 2022, under the EU Merger Regulation, the acquisition of sole control of Unilabs Holding AB (‘Unilabs’) of Switzerland by APMH Invest A/S (‘APMHI’) of Denmark.

Unilabs provides diagnostic services, including bio-medical testing services, medical imaging services, reproductive medicine services and drug development services.

APMHI is a globally active investment company controlled by A.P. Møller Holding A/S of Denmark. The Commission concluded that the proposed acquisition would not raise competition concerns, because of its limited impact on the market. The transaction was examined under the simplified merger review procedure. More information is available on the Commission’sCommission’s competition, in the public case register under the case number M.10585.